Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$30,000.00
May 1, 2026
For-profit organization
Ostia - YEP
1042498
The youth is conducting in vitro research on Streptococcus salivarius SALI-10™, an advanced oral probiotic strain that produces unique phosphorylated lantibiotics with antimicrobial activity. Her work expands Ostia’s R&D into respiratory pathogens, exploring the versatility and cross-system effects of this probiotic strain. The project evaluates SALI-10™’s ability to limit colonization by Streptococcus pneumoniae, Streptococcus pyogenes, and Micrococcus luteus, and determines whether these effects result from direct antimicrobial activity or immune cell priming that enhances antibacterial responses.
$30,000.00
Nov 3, 2025
For-profit organization
Youth Employment
1037036
The youth will support Ostia’s translational research and clinical development programs for S. salivarius SALI-10®, a next-generation oral probiotic producing novel phosphorylated lantibiotics. This work will contribute to a key clinical trial evaluating SALI-10’s ability to reduce gingivitis and prevent dysbiosis in otherwise healthy individuals. This work also underpins Ostia’s regulatory filings with Health Canada (NHP, Class III NPN) and the US FDA GRAS pathway, advancing the company’s commercialization strategy.